HK1060855A1 - Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function - Google Patents

Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function

Info

Publication number
HK1060855A1
HK1060855A1 HK04103932A HK04103932A HK1060855A1 HK 1060855 A1 HK1060855 A1 HK 1060855A1 HK 04103932 A HK04103932 A HK 04103932A HK 04103932 A HK04103932 A HK 04103932A HK 1060855 A1 HK1060855 A1 HK 1060855A1
Authority
HK
Hong Kong
Prior art keywords
ofdelayed
medicament
manufacture
treatment
graft function
Prior art date
Application number
HK04103932A
Other languages
English (en)
Inventor
Marc Bigaud
Volker Brinkmann
Tomasz Sablinski
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0104438A external-priority patent/GB0104438D0/en
Priority claimed from GB0105000A external-priority patent/GB0105000D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1060855A1 publication Critical patent/HK1060855A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK04103932A 2001-02-22 2004-06-01 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function HK1060855A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0104438A GB0104438D0 (en) 2001-02-22 2001-02-22 Organic compounds
GB0105000A GB0105000D0 (en) 2001-02-28 2001-02-28 Organic compounds
PCT/EP2002/001860 WO2002067915A1 (en) 2001-02-22 2002-02-21 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function

Publications (1)

Publication Number Publication Date
HK1060855A1 true HK1060855A1 (en) 2004-08-27

Family

ID=26245749

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04103932A HK1060855A1 (en) 2001-02-22 2004-06-01 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function

Country Status (12)

Country Link
US (2) US20040087662A1 (zh)
EP (1) EP1368015B1 (zh)
JP (1) JP4318921B2 (zh)
CN (1) CN100479814C (zh)
AT (1) ATE335475T1 (zh)
BR (1) BR0207434A (zh)
CA (1) CA2435739A1 (zh)
DE (1) DE60213766T2 (zh)
ES (1) ES2267993T3 (zh)
HK (1) HK1060855A1 (zh)
PT (1) PT1368015E (zh)
WO (1) WO2002067915A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2322442T3 (es) * 2001-06-08 2009-06-22 Novartis Ag Tratamiento o profilaxis del rechazo de injertos de celulas productoras de insulina.
CA2473461C (en) 2002-01-11 2011-11-01 Sankyo Company, Limited Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
BRPI0507944A (pt) 2004-02-24 2007-07-24 Sankyo Co composição farmacêutica
SI1772145T1 (sl) * 2004-07-16 2011-06-30 Kyorin Seiyaku Kk Postopek za učinkovito uporabo zdravila in postopek za preprečevanje stranskih učinkov
US7795472B2 (en) * 2004-10-12 2010-09-14 Kyorin Pharmaceutical Co., Ltd. Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride and hydrates thereof, and intermediates in the production thereof
BRPI0617077A2 (pt) * 2005-10-07 2015-01-06 Kyorin Seiyaku Kk Agente terapêutico para tratamento de doenças do fígado contendo 2-amina-1, 3-propanediol derivativo como ingrediente ativo, e método para tratamento de doenças do fígado
TWI389683B (zh) * 2006-02-06 2013-03-21 Kyorin Seiyaku Kk A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
KR20090041424A (ko) * 2006-08-08 2009-04-28 교린 세이야꾸 가부시키 가이샤 아미노알코올 유도체 및 그것들을 유효성분으로 하는 면역 억제제
WO2008018427A1 (fr) * 2006-08-08 2008-02-14 Kyorin Pharmaceutical Co., Ltd. Dérivé d'ester de l'acide aminophosphorique et modulateur du récepteur s1p contenant ledit dérivé en tant que principe actif
US8476305B2 (en) 2008-02-07 2013-07-02 Kyorin Pharmaceutical Co., Ltd. Therapeutic agent or prophylactic agent for inflammatory bowel disease comprising amino alcohol derivative as active ingredient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928572A (en) * 1971-02-11 1975-12-23 Ayerst Mckenna & Harrison Myriocin and process of preparation
DK0627406T3 (da) * 1992-10-21 1999-07-12 Taito Co 2-Amino-1,3-propandiolforbindelser og immunundertrykkende midler
EP0812588B1 (en) * 1995-12-28 2004-10-13 Mitsubishi Pharma Corporation Pharmaceutical external preparations for topical administration comprising 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol for the treatment of diseases induced from immune disorder
GB9624038D0 (en) * 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
PT1002792E (pt) * 1997-04-04 2004-12-31 Mitsubishi Pharma Corp Compostos de 2-aminopropano-1,3-diol, sua utilizacao medicinal e intermediariosda sintese dos mesmos
JPH1180026A (ja) * 1997-09-02 1999-03-23 Yoshitomi Pharmaceut Ind Ltd 新規免疫抑制剤、その使用方法およびその同定方法
ES2322442T3 (es) * 2001-06-08 2009-06-22 Novartis Ag Tratamiento o profilaxis del rechazo de injertos de celulas productoras de insulina.

Also Published As

Publication number Publication date
CN100479814C (zh) 2009-04-22
JP4318921B2 (ja) 2009-08-26
PT1368015E (pt) 2006-12-29
JP2004527490A (ja) 2004-09-09
DE60213766T2 (de) 2007-08-02
ATE335475T1 (de) 2006-09-15
US20080015261A1 (en) 2008-01-17
CN1492757A (zh) 2004-04-28
EP1368015A1 (en) 2003-12-10
DE60213766D1 (de) 2006-09-21
CA2435739A1 (en) 2002-09-06
US20040087662A1 (en) 2004-05-06
EP1368015B1 (en) 2006-08-09
BR0207434A (pt) 2004-07-06
ES2267993T3 (es) 2007-03-16
WO2002067915A1 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
WO2003105757A3 (en) METHODS AND COMPOSITIONS FOR MEDIA-DEPENDENT BINDING OF A TARGET AGENT TO A TARGET
AU2001273276A1 (en) Improving effectiveness of medical stents by gcib
TW200714283A (en) Method and composition for treating peripheral vascular diseases
WO2003000200A3 (en) β-2'-OR 3'-HALONUCLEOSIDES
UA88418C2 (ru) Синергическая фунгицидная комбинация активных веществ и их применение для борьбы с нежелательными фитопатогенными грибами
DE60235928D1 (de) Mittel zur Suppression von Transplantat-Abstossung
PL1646634T3 (pl) Zastosowanie rapamycyny i pochodnych rapamycyny w leczeniu utraty kości
HK1047404A1 (en) Vascular coating composition
AU8841801A (en) Switchable tackiness coating compositions for ophthalmic implants
MXPA06000123A (es) Suspension aislante de apoyo central de resorte rapido de plastico y metodo para fabricar y ensamblar el mismo.
WO2004031129A3 (en) Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
AU1565300A (en) Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol
WO2006034001A3 (en) Methods of treating hiv infection
WO2003103662A3 (en) GLYCOPROTEIN VI INHIBITORS
HK1060855A1 (en) Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function
DK1178726T3 (da) Vandig opløsning til konservering af væv og organer
DE60335202D1 (en) Chaperonin-10-immunosuppression
MXPA04003755A (es) Endoprotesis vasculares.
WO2004091436A3 (en) Methods and compositions for treating ocular disease
GB2454154A (en) Aglet for attachment to a graft material
WO2007016580A3 (en) Silencing rna molecules and their use in bone formation
MXPA05012742A (es) Composiciones de tratamiento para el cabello.
TW200514553A (en) Therapeutic agent for hepatitis C
NZ332412A (en) use of interleuklin-10 for treating or preventing ischemia-reperfusion injury

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100221